Earnings Call · Q2 FY2023·2023-08-10

Q2 23EPS -36.96%·Rev n/aQ1 23EPS -52.78%·Rev n/aQ4 22EPS +24.39%·Rev n/aQ3 22EPS +35.29%·Rev n/a⚠ consensus missing

AVITA Medical, Inc. RCEL

Jessica Ekeberg — Investor Relations

James Corbett — Chief Executive Officer

David O'Toole — Chief Financial Officer

+1.5%1d on move date+1.5% vs SPY3d+1.6%5d−7.3%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more RCEL calls or request research access.

More RCEL calls Browse calls Request research access